42 U.S.C. § 285e–10a
Alzheimer’s clinical research and training awards
United States · Title 42 — THE PUBLIC HEALTH AND WELFARE · Status: effective
Cite this
- Citation
- 42 U.S.C. § 285e–10a, Alzheimer’s clinical research and training awards, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/475602
- Permanent ID
ys:prov:475602@1- SHA-256
dc80f4082406f58177bfac122eaedc4524ac6c373875c18ffe9455c2300fb1ef
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
The Director of the Institute is authorized to establish and maintain a program to enhance and promote the translation of new scientific knowledge into clinical practice related to the diagnosis, care and treatment of individuals with Alzheimer’s disease.
In order to foster the application of the most current developments in the etiology, pathogenesis, diagnosis, prevention and treatment of Alzheimer’s disease, amounts made available under this section shall be directed to the support of promising clinicians through awards for research, study, and practice at centers of excellence in Alzheimer’s disease research and treatment.
Research shall be carried out under awards made under subsection (b) in environments of demonstrated excellence in neuroscience, neurobiology, geriatric medicine, and psychiatry and shall foster innovation and integration of such disciplines or other environments determined suitable by the Director of the Institute.
Legislative history
The public laws that enacted or amended this section. Tallies are for the whole bill as it passed each chamber — often an omnibus covering far more than this provision — not a vote on this section alone.
- Public Health Improvement ActHouse: no recorded tallySenate: no recorded tally
- National Institutes of Health Reform Act of 2006House: 414–2Senate: no recorded tally